Market Overview:

The intragastric balloons market is experiencing rapid growth, driven by rising global obesity rates, demand for minimally invasive procedures, and technological advancements in balloon design. According to IMARC Group's latest research publication, "Intragastric Balloons Market Report by Product (Single Intragastric Balloon, Double Intragastric Balloon, Triple Intragastric Balloon), Filling Material (Saline Filling, Gas Filling), Implanting Procedure (Surgical, Non-Surgical), Application (Obesity, Diabetes, Diet Control, Weight-Loss, Pre-Operative Weight Reduction, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033", The global intragastric balloons market size reached USD 70.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 169.6 Million by 2033, exhibiting a growth rate (CAGR) of 9.79% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers  and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/intragastric-balloons-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Intragastric Balloons Market

• Rising Global Obesity Rates:

The increasing prevalence of obesity worldwide is a significant driver for the intragastric balloons market. Obesity, linked to health issues like diabetes, heart disease, and certain cancers, has prompted individuals to seek effective weight-loss solutions. Intragastric balloons offer a non-surgical option, appealing to those who have struggled with diet and exercise. For instance, the World Health Organization highlights the global obesity epidemic, noting that millions are affected, creating a demand for minimally invasive interventions. This trend is particularly evident in regions like North America, where lifestyle factors contribute to high obesity rates, fueling the adoption of intragastric balloons as a practical solution.

• Demand for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly favoring minimally invasive weight-loss treatments due to their reduced risks, shorter recovery times, and lower complication rates compared to traditional bariatric surgeries. Intragastric balloons, inserted via endoscopy or swallowable capsules, align with this preference. A case study from the American Society for Metabolic and Bariatric Surgery shows thousands of successful balloon procedures in the U.S., reflecting patient satisfaction with quicker recovery and minimal discomfort. This shift toward less invasive options is driving market growth, as individuals seek effective yet safer alternatives to manage obesity and improve overall health outcomes.

• Technological Advancements in Balloon Design:

Innovations in intragastric balloon technology are propelling market expansion by enhancing safety, efficacy, and patient comfort. Modern balloons, such as Allurion’s swallowable Elipse balloon, eliminate the need for endoscopy, making the procedure more accessible. Additionally, adjustable balloons, like those from Spatz FGIA, allow volume modifications to optimize weight loss. These advancements reduce side effects like nausea and improve durability. For example, Apollo Endosurgery’s Orbera balloon has been refined to enhance patient outcomes, contributing to its widespread adoption. Such technological progress encourages both patients and providers to embrace intragastric balloons as a reliable weight-loss solution.

Key Trends in the Intragastric Balloons Market

• Shift Toward Personalized Weight Management:

The intragastric balloons market is witnessing a trend toward personalized treatment plans tailored to individual patient needs, such as age, BMI, and health conditions. This approach enhances outcomes by aligning balloon therapy with specific patient profiles. For instance, healthcare providers in Europe are customizing balloon placements based on patient data, leading to higher satisfaction rates. Clinics are also integrating digital health tools, like telemedicine, to monitor progress and adjust dietary plans. This trend reflects a broader shift in healthcare toward patient-centric solutions, making intragastric balloons a more appealing and effective option for diverse populations seeking weight loss.

• Expansion of Reimbursement Policies:

Favorable reimbursement policies are emerging as a key trend, particularly in developed regions like North America and Europe. Insurance providers, such as Medicaid and private insurers like Aetna, are increasingly covering intragastric balloon procedures for patients with severe obesity and comorbidities. This trend improves accessibility, as seen in the U.S., where coverage has expanded due to the long-term cost benefits of weight loss. By reducing financial barriers, these policies encourage more patients to opt for balloons over costly surgical alternatives, boosting market demand and supporting broader adoption of this non-surgical weight-loss method.

• Growth in Medical Tourism:

Medical tourism is a growing trend in the intragastric balloons market, particularly in emerging economies like India and Brazil. Patients are traveling to these regions for cost-effective, high-quality procedures, driven by lower treatment costs and advanced healthcare facilities. For example, Allurion Technologies has expanded its Elipse balloon program to countries like Mexico and Brazil, attracting international patients. This trend is supported by the rise in specialized weight-loss clinics and favorable regulatory environments in these regions. As medical tourism grows, it enhances market penetration, making intragastric balloons a globally accessible solution for obesity management.

Leading Companies Operating in the Global Intragastric Balloons Industry:

• being Apollo Endosurgery
• Obalon Therapeutics Inc.
• ReShape Medical Inc.
• Medicone
• Medsil
• Allurion Technologies Inc.
• Helioscopie
• Spatz Fgia Inc.
• PlenSat
• Districlass Medical SA
• Endalis
• Lexel SRL
• Silimed Inc.
• Shandong Institute of Medical Instruments

Insurtech Market Report Segmentation:

Breakup by Product:

• Single Intragastric Balloon
• Double Intragastric Balloon
• Triple Intragastric Balloon

Breakup by Implanting Procedure:

• Surgical
• Non-Surgical

Breakup by Application:

• Obesity
• Diabetes
• Diet Control
• Weight-Loss
• Pre-Operative Weight Reduction
• Others

Breakup by End-User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145